-
1.发明申请公开(公告)号：US20210317402A1
公开(公告)日：2021-10-14
申请号：US17355295
申请日：2021-06-23
Applicant: Inscripta, Inc.
Inventor： Eric Abbate , Katherine Krouse , Nandini Krishnamurthy , Richard Fox , Daniel Held , Michael Clay , Krishna Yerramsetty
IPC: C12N1/20 , C07K14/245
Abstract: The present disclosure relates to various different types of variants in E. coli coding and noncoding regions leading to enhanced lysine production for, e.g., supplements and nutraceuticals.
-
2.发明授权公开(公告)号：US10920189B2
公开(公告)日：2021-02-16
申请号：US16904827
申请日：2020-06-18
Applicant: Inscripta, Inc.
Inventor： Richard Fox , Daniel Held , Eric Abbate , Michael Clay , Katherine Krouse , Nandini Krishnamurthy , Krishna Yerramsetty
IPC: C12N1/20 , C07K14/245
Abstract: The present disclosure relates to various different types of variants in E. coli coding and noncoding regions leading to enhanced lysine production for, e.g., supplements and nutraceuticals.
-
Patent Agency Ranking
公开(公告)号：US20210363481A1
公开(公告)日：2021-11-25
申请号：US17319006
申请日：2021-05-12
Applicant: Inscripta, Inc.
Inventor： Eric Abbate , Katherine Krouse , Richard Fox , Daniel Held , Michael Clay , Nandini Krishnamurthy
Abstract: The present disclosure relates to various different types of mutations in the thrA gene in E. coli leading to enhanced lysine production for, e.g., supplements and nutraceuticals.
-
4.发明申请公开(公告)号：US20210155894A1
公开(公告)日：2021-05-27
申请号：US17159137
申请日：2021-01-26
Applicant: Inscripta, Inc.
Inventor： Richard Fox , Daniel Held , Eric Abbate , Michael Clay , Katherine Krouse , Nandini Krishnamurthy , Krishna Yerramsetty
IPC: C12N1/20 , C07K14/245
Abstract: The present disclosure relates to various different types of variants in E. coli coding and noncoding regions leading to enhanced lysine production for, e.g., supplements and nutraceuticals.
-
5.发明授权公开(公告)号：US11078458B2
公开(公告)日：2021-08-03
申请号：US17159137
申请日：2021-01-26
Applicant: Inscripta, Inc.
Inventor： Richard Fox , Daniel Held , Eric Abbate , Michael Clay , Katherine Krouse , Nandini Krishnamurthy , Krishna Yerramsetty
IPC: C12N1/20 , C07K14/245
Abstract: The present disclosure relates to various different types of variants in E. coli coding and noncoding regions leading to enhanced lysine production for, e.g., supplements and nutraceuticals.
-
6.发明申请公开(公告)号：US20210095243A1
公开(公告)日：2021-04-01
申请号：US17026359
申请日：2020-09-21
Applicant: Inscripta, Inc.
Inventor： Bryan Leland , Michael Clay , Eric Abbate , Stephen Federowicz , Richard Fox
Abstract: The present disclosure relates to various different types of mutations in S. cerevisiae leading to enhanced tyrosine production for, e.g., supplements and nutraceuticals.
-
公开(公告)号：US11787841B2
公开(公告)日：2023-10-17
申请号：US17319006
申请日：2021-05-12
Applicant: Inscripta, Inc.
Inventor： Eric Abbate , Katherine Krouse , Richard Fox , Daniel Held , Michael Clay , Nandini Krishnamurthy
IPC: A61K39/108 , C07K14/245
CPC classification number: C07K14/245 , A61K39/0258
Abstract: The present disclosure relates to various different types of mutations in the thrA gene in E. coli leading to enhanced lysine production for, e.g., supplements and nutraceuticals.
-
-
-
-
-
-
Search Results
7
records
(took 0.012 seconds)
